Inventor · disambiguated record
Stephen D. Wolpe
Also filed as: TSYRLOVA IRENA · WOLPE STEPHEN · WOLPE STEPHEN D
32 granted patents·17 pending applications·341 citations·filing 1994–2024
97Inventor score
Files withUNIV ROCKEFELLER16WELLSTAT THERAPEUTICS CORP16TARGAZYME INC8PRO NEURON INC3KHLORIS BIOSCIENCES INC2
Top patents by PatentIndex Score
49 records- 0191US7851494B2Method for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Dec 14, 2010·9 cites·6 claims
- 0290US5698419AMonoclonal antibodies to cachectin/tumor necrosis factor and methods for preparing sameUNIV ROCKEFELLER·Filed 1995·Granted Dec 16, 1997·84 cites·14 claims
- 0386US10934284B2Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2019·Granted Mar 2, 2021·2 cites·7 claims
- 0484US10030015B2Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2014·Granted Jul 24, 2018·3 cites·17 claims
- 0584US5861483AInhibitor of stem cell proliferation and uses thereofPRO NEURON INC·Filed 1996·Granted Jan 19, 1999·48 cites·15 claims
- 0683US7514555B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Apr 7, 2009·16 cites·22 claims
- 0781US5616688AMacrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1994·Granted Apr 1, 1997·33 cites·15 claims
- 0881US2025034139A1Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activityPHARMA CINQ LLC·Filed 2024·Application pending·0 cites
- 0980US8178675B2Compounds for the treatment of metabolic disordersROMANTSEV FEDOR EVGENIEVICH·Filed 2006·Granted May 15, 2012·8 cites·3 claims
- 1080US7973052B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2009·Granted Jul 5, 2011·3 cites·6 claims
- 1179US7115267B2Stimulator of stem cell divisionWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Oct 3, 2006·9 cites·8 claims
- 1277US2025115867A1Augmentation of cell therapy efficacy including treatment with alpha, 1,3 fucosyltransferaseTARGAZYME INC·Filed 2024·Application pending·0 cites
- 1375US6858583B2Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferationWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Feb 22, 2005·2 cites·1 claims
- 1475US2024271093A1Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferaseTARGAZYME INC·Filed 2024·Application pending·0 cites
- 1572US7645772B2Treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Jan 12, 2010·6 cites·7 claims
- 1670US12139483B2Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activityPHARMA CINQ LLC·Filed 2021·Granted Nov 12, 2024·0 cites·19 claims
- 1768US2010041147A1Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferationWELLSTAT THERAPEUTICS CORP·Filed 2009·Application pending·0 cites
- 1868US2023014609A1Manufacture and cryopreservation of fucosylated cells for therapeutic useTARGAZYME INC·Filed 2022·Application pending·0 cites
- 1967US2008015209A1Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 2066US8604083B2Method for the treatment of metabolic disordersSHARMA SHALINI·Filed 2007·Granted Dec 10, 2013·0 cites·7 claims
- 2166US5939391AHemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferationPRO NEURON INC·Filed 1995·Granted Aug 17, 1999·19 cites·7 claims
- 2265US2005043218A1Inhibitor of stem cell proliferation and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2004·Application pending·0 cites
- 2362US11976298B2Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferaseTARGAZYME INC·Filed 2018·Granted May 7, 2024·0 cites·7 claims
- 2460US2019062694A1Manufacture and Cryopreservation of Fucosylated Cells for Therapeutic UseTARGAZYME INC·Filed 2018·Application pending·0 cites
- 2559US5817763AMacrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Oct 6, 1998·6 cites·9 claims
- 2659US2018298000A1Aminoquinoline compounds having anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 2758US2014161782A1Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucoslytransferaseTARGAZYME INC·Filed 2014·Application pending·0 cites
- 2858US2006166863A1Inhibitor and stimulator of stem cell proliferation and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
- 2957US6784155B1Inhibitor and stimulator of stem cell proliferation and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 1997·Granted Aug 31, 2004·10 cites·15 claims
- 3055US5989836AMethod for measuring the binding sites for macrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Nov 23, 1999·5 cites·6 claims
- 3154US6019969AComposition comprising antibody to macrophage-derived inflammatory mediator (MIP-α 1 and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Feb 1, 2000·9 cites·14 claims
- 3254US2010227809A1Combination treatment for metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 3353US5700466AMethod of ameliorating or preventing septic shock using a monoclonal antibody specific to cachectin/tumor necrosis factorUNIV ROCKEFELLER·Filed 1994·Granted Dec 23, 1997·13 cites·2 claims
- 3453US2017058261A1Augmentation of Cell Therapy Efficacy Including Treatment With Alpha 1,3 FucosyltransferaseTARGAZYME INC·Filed 2016·Application pending·0 cites
- 3551US2017121673A1Manufacture and Cryopreservation of Fucosylated Cells for Therapeutic UseTARGAZYME INC·Filed 2015·Application pending·0 cites
- 3650US6046309AMacrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Apr 4, 2000·8 cites·22 claims
- 3750US5760186AAntibody to macrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Jun 2, 1998·4 cites·15 claims
- 3849US6090782AHemoglobin alpha and beta chain peptide fragments useful for inhibiting stem cell proliferationPRO NEURON INC·Filed 1998·Granted Jul 18, 2000·7 cites·19 claims
- 3949US2023181708A1Ipsc-based vaccine as a prophylactic and therapeutic treatment for cancerKHLORIS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4048US5863535AMacrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Jan 26, 1999·4 cites·16 claims
- 4148US2013137629A1Combination treatment for metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2013·Application pending·0 cites
- 4248US2022387569A1Induced pluripotent stem cell-based cancer vaccinesKHLORIS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4347US5942222AMethods of treating granulocyte-macrophage progenitor cell-derived blood cell dysfunctionUNIV ROCKEFELLER·Filed 1995·Granted Aug 24, 1999·5 cites·5 claims
- 4444US5849873AMacrophage-derived inflammatory mediator (MIP-1 α and MIP-1 β)UNIV ROCKEFELLER·Filed 1995·Granted Dec 15, 1998·4 cites·9 claims
- 4539US5703206AMacrophage inflammatory protein 2 (MIP-2)UNIV ROCKEFELLER·Filed 1994·Granted Dec 30, 1997·8 cites·12 claims
- 4639US5650147AMethods of stimulating granulocyte-macrophage progenitor cellsUNIV ROCKEFELLER·Filed 1994·Granted Jul 22, 1997·6 cites·8 claims
- 4738US5741484AMacrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Apr 21, 1998·5 cites·9 claims
- 4838US5717074AMacrophage-derived inflammatory mediator (MIP-2)UNIV ROCKEFELLER·Filed 1995·Granted Feb 10, 1998·2 cites·8 claims
- 4937US6103234AComposition comprising an antibody to macrophage-derived inflammatory mediator (MIP-2)UNIV ROCKEFELLER·Filed 1995·Granted Aug 15, 2000·3 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →